Trials / Recruiting
RecruitingNCT06543979
Anorectal Manometery in Pediatric Chronic Refractory Constipation
The Diagnostic Value of Anorectal Manometry in Pediatric Chronic Refractory Constipation With or Without Fecal Incontinence
- Status
- Recruiting
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Ain Shams University · Academic / Other
- Sex
- All
- Age
- 4 Years – 16 Years
- Healthy volunteers
- Not accepted
Summary
Anorectal manometry and high-resolution anorectal manometry (HRAM) are becoming the investigation of choice for understanding the pathophysiology of chronic constipation with or without fecal incontenance in children in many institutions. In high resolution anorectal manometery we are able to gain information whether the symptoms are related to sphincter dysfunction, impaired sensation, or pelvic floor dyssynergia
Detailed description
Primary objective: To assess different patterns of anorectal manometry in children with chronic refractory constipation with or without fecal incontinence. Secondary objective: To determine the effectiveness of different modalities of treatment of chronic refractory constipation based on the anorectal findings. To assess the safety ,tolerability and effectiveness of lubiprostone in pediatric age group with chronic refractory constipation. To assess the effect of elimination of cow milk products in patient with chronic refractory constipation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | lubiprostone , single arm | laxative |
| PROCEDURE | biofeed back sessions | Biofeedback for participants with dyssynergic defecation and participants with reduced rectal sensations |
| PROCEDURE | botox injection | Botulinum toxin injection for participants suffering from elevated anal canal pressure |
Timeline
- Start date
- 2024-09-07
- Primary completion
- 2025-09-01
- Completion
- 2025-10-01
- First posted
- 2024-08-09
- Last updated
- 2024-10-09
Locations
1 site across 1 country: Egypt
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06543979. Inclusion in this directory is not an endorsement.